drugset / Trial / NCT01425190
Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P07614)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a study to determine the pharmacokinetics (PK) and weight-based dose of boceprevir following single oral dose administration in Chronic Hepatitis C Virus (HCV) pediatric participants.
Timeline
- Start
- 2012-01-04
- Primary completion
- 2013-03-20
- Completion
- 2013-03-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Boceprevir | Small molecule | 11.4 mg/kg | Oral |